Gratus Capital’s Biogen BIIB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-905	Closed	-$251K	–	219
2022 Q4	$251K	Sell	905 -130	-13%	-$36K	0.02%	195
2022 Q3	$276K	Hold	1,035	–	–	0.03%	170
2022 Q2	$211K	Hold	1,035	–	–	0.02%	176
2022 Q1	$218K	Sell	1,035 -2	-0.2%	-$421	0.02%	189
2021 Q4	$249K	Buy	1,037 +2	+0.2%	+$480	0.02%	182
2021 Q3	$293K	Buy	1,035 +173	+20%	+$49K	0.03%	162
2021 Q2	$298K	Sell	862 -188	-18%	-$65K	0.03%	161
2021 Q1	$294K	Hold	1,050	–	–	0.04%	160
2020 Q4	$257K	Hold	1,050	–	–	0.03%	159
2020 Q3	$298K	Hold	1,050	–	–	0.05%	140
2020 Q2	$281K	Sell	1,050 -61	-5%	-$16.3K	0.05%	137
2020 Q1	$351K	Buy	1,111 +61	+6%	+$19.3K	0.07%	126
2019 Q4	$312K	Hold	1,050	–	–	0.05%	149
2019 Q3	$244K	Hold	1,050	–	–	0.04%	153
2019 Q2	$246K	Hold	1,050	–	–	0.04%	153
2019 Q1	$248K	Sell	1,050 -250	-19%	-$59K	0.04%	154
2018 Q4	$391K	Buy	1,300 +250	+24%	+$75.2K	0.08%	138
2018 Q3	$371K	Hold	1,050	–	–	0.05%	146
2018 Q2	$305K	Hold	1,050	–	–	0.05%	144
2018 Q1	$288K	Buy	1,050 +130	+14%	+$35.7K	0.04%	153
2017 Q4	$293K	Hold	920	–	–	0.04%	156
2017 Q3	$288K	Hold	920	–	–	0.04%	156
2017 Q2	$250K	Hold	920	–	–	0.04%	160
2017 Q1	$252K	Hold	920	–	–	0.04%	155
2016 Q4	$261K	Hold	920	–	–	0.04%	156
2016 Q3	$288K	Hold	920	–	–	0.04%	154
2016 Q2	$222K	Sell	920 -130	-12%	-$31.4K	0.03%	165
2016 Q1	$273K	Hold	1,050	–	–	0.06%	56
2015 Q4	$322K	Hold	1,050	–	–	0.07%	74
2015 Q3	$306K	Hold	1,050	–	–	0.07%	80
2015 Q2	$424K	Sell	1,050 -300	-22%	-$121K	0.1%	73
2015 Q1	$570K	Buy	+1,350	New	+$570K	0.13%	72